Laboratory Corporation of America Holdings LH:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 3:25 PM EST
236.12quote price arrow down-8.37 (-3.43%)
Volume
536,411
52 week range
98.02 - 252.45

...

Loading . . .

KEY STATS

  • Open242.30
  • Day High244.74
  • Day Low235.03
  • Prev Close244.50
  • 52 Week High252.45
  • 52 Week High Date02/17/21
  • 52 Week Low98.02
  • 52 Week Low Date03/19/20
  • Market Cap22.999B
  • Shares Out97.40M
  • 10 Day Average Volume1.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.04
  • 1 Year % Change28.23

RATIOS/PROFITABILITY

  • EPS (TTM)15.82
  • P/E (TTM)14.92
  • Fwd P/E (NTM)9.20
  • EBITDA (MRQ)3.643B
  • ROE (MRQ)18.39%
  • Revenue (MRQ)13.979B
  • Gross Margin (MRQ)35.43%
  • Net Margin (MRQ)11.14%
  • Debt To Equity (MRQ)62.90%

EVENTS

  • Earnings Date04/27/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

QUOTE FINDER

Profile

MORE
Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing...
Adam Schechter
President
Glenn Eisenberg
Chief Financial Officer
Sandra Van Der Vaart
Executive Vice President
Brian Caveney M.D., J.D.
Executive Vice President
Paul Kirchgraber
Executive Vice President
Address
358 S MAIN ST
Burlington, NC
27215-5837
United States